Toll Free: 1-888-928-9744

Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2016

Published: Apr 20, 2016 | Pages: 198 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2016" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Renal Failure (ARF) (Acute Kidney Injury). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical Trials 15 Clinical Trials by Phase in G7 Countries 17 Clinical Trials in G7 Countries by Trial Status 18 Clinical Trials by E7 Countries: Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical Trials 19 Clinical Trials by Phase in E7 Countries 21 Clinical Trials in E7 Countries by Trial Status 22 Clinical Trials by Phase 23 In Progress Trials by Phase 24 Clinical Trials by Trial Status 25 Clinical Trials by End Point Status 26 Subjects Recruited Over a Period of Time 27 Clinical Trials by Sponsor Type 28 Prominent Sponsors 29 Top Companies Participating in Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials 31 Prominent Drugs 33 Latest Clinical Trials News on Acute Renal Failure (ARF) (Acute Kidney Injury) 34 Mar 14, 2016: NeuroVive announces the CiPRICS study enrols 100 patients and reports favourable safety evaluation 34 Mar 14, 2016: Quark Pharmaceuticals Doses First Patient In Two Pivotal Clinical Studies of RNAi-Based Therapeutic QPI-1002 34 Feb 29, 2016: Thrasos Announces Promising Results for Phase II THR-184 Dose Ranging Clinical Study for the Prevention of Acute Kidney Injury (AKI) 35 Clinical Trial Profile Snapshots 36 Appendix 195 Abbreviations 195 Definitions 195 Research Methodology 196 Secondary Research 196 About GlobalData 197 Contact Us 197 Disclaimer 197 Source 198
List of Tables
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials by Region, 2016* 6 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, North America, Top Countries, 2016* 12 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 13 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14 Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2016* 16 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18 Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2016* 20 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 21 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 22 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials by Phase, 2016* 23 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 24 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 25 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 26 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 27 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 28 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 30 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 32 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 33


List of Figures
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 13 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 14 Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2016* 15 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18 Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2016* 19 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 21 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 22 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 23 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 24 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 25 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 26 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 27 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 28 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 29 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 31 Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 33 GlobalData Methodology 196

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global non halogenated flame retardants market size is anticipated to be valued at USD 2.54 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing safety materials demand owing to low heat & smoke emission properties in c

Read More...

Global polymethyl methacrylate (PMMA) market size is likely to be valued at USD 11.65 billion by 2022; as per a new research report by Radiant Insights, Inc. Increasing spending on advertising & marketing for building strong brand equity and product

Read More...

Global Automated Test Equipment (ATE) market is expected to be valued at USD 4.48 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing design complexity coupled with need for effective testing is expected to drive the gl

Read More...

Global aerosol propellants market is anticipated to reach USD 24.8 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing popularity of personal care and cosmetics products such as hair sprays, deodorants and shaving cream

Read More...

Global automotive electronics market size forecast is likely to reach USD 279.96 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing application scope of these equipments is estimated to drive industry growth. Increasing i

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify